|Bid||218.28 x 300|
|Ask||0.00 x 0|
|Day's Range||218.98 - 220.00|
|52 Week Range||175.58 - 222.50|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.15%|
Promacta was discovered by Ligand Pharmaceuticals (LGND) and GlaxoSmithKline (GSK) as a part of their thrombopoietin (or TPO) receptor agonist research collaboration.
Economic expansion prompted by Trump's win and Fed's monetary policy are the two major driving forces of the small cap stocks performance.
Zacks Investment Ideas feature highlights: S&P 500 Pure Value ETF, PowerShares, SPDR S&P 600 Small Cap Value ETF, SPDR S&P 600 Small Cap Growth ETF, iShares Morningstar Small Cap Value ETF